Alcinous Pharmaceuticals
Rumford
About Alcinous Pharmaceuticals
Alcinous Pharmaceuticals designs and develops new molecules that modulate the activity of well-established protein targets related to oncology and other pathologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $600.0K
- Funding stage: Seed
- Last round: Seed (May 2020)
- Website: alcinouspharmaceuticals.com
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alcinous-pharmaceuticals-198704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.